Zur Kurzanzeige

dc.contributor.authorGómez Cuadrado, Laura
dc.contributor.authorBullock, Esme
dc.contributor.authorMabruk, Zeanap
dc.contributor.authorZhao, Hong
dc.contributor.authorSouleimanova, Margarita
dc.contributor.authorNoer, Pernille Rimmer
dc.contributor.authorTurnbull, Arran K.
dc.contributor.authorOxvig, Claus
dc.contributor.authorBertos, Nicholas
dc.contributor.authorByron, Adam
dc.contributor.authorDixon, J. Michael
dc.contributor.authorPark, Morag
dc.contributor.authorHaider, Syed
dc.contributor.authorNatrajan, Rachael
dc.contributor.authorSims, Andrew H.
dc.contributor.authorBrunton, Valerie G.
dc.date.accessioned2024-12-18T09:12:44Z
dc.date.available2024-12-18T09:12:44Z
dc.date.issued2022-02
dc.identifier.urihttp://hdl.handle.net/10259/9801
dc.description.abstractnvasive lobular carcinoma (ILC) is the second most common histological subtype of breast cancer, and it exhibits a number of clinico-pathological characteristics distinct from the more common invasive ductal carcinoma (IDC). We set out to identify alterations in the tumor microenvironment (TME) of ILC. We used laser-capture microdissection to separate tumor epithelium from stroma in 23 ER+ ILC primary tumors. Gene expression analysis identified 45 genes involved in regulation of the extracellular matrix (ECM) that were enriched in the non-immune stroma of ILC, but not in non-immune stroma from ER+ IDC or normal breast. Of these, 10 were expressed in cancer-associated fibroblasts (CAFs) and were increased in ILC compared to IDC in bulk gene expression datasets, with PAPPA and TIMP2 being associated with better survival in ILC but not IDC. PAPPA, a gene involved in IGF-1 signaling, was the most enriched in the stroma compared to the tumor epithelial compartment in ILC. Analysis of PAPPA- and IGF1-associated genes identified a paracrine signaling pathway, and active PAPP-A was shown to be secreted from primary CAFs. This is the first study to demonstrate molecular differences in the TME between ILC and IDC identifying differences in matrix organization and growth factor signaling pathways.es
dc.description.sponsorshipThis work was funded by Cancer Research UK (C157/A23219 to LGC; C157/A29279 to E.B.) and the Cancer Research UK Edinburgh Centre Award (C157/A18075), an Endeavour Scholarship (734/2018/878 to Z.M.) and Programme Grants from Breast Cancer Now as part of Programme Funding to the Breast Cancer Now Toby Robins Research Centre (S.H. and R.N.). The breast tissue and data bank at McGill University is supported by funding from the Database and Tissue Bank Axis of the Réseau de Recherche en Cancer of the Fonds de Recherche du Québec-Santé and the Quebec Breast Cancer Foundation (to M.P.).es
dc.language.isoenges
dc.publisherMDPIes
dc.relation.ispartofCancers. 2022, V. 14, n. 4, p. 904es
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectLobular breast canceres
dc.subjectTumor microenvironmentes
dc.subjectCancer-associated fibroblastses
dc.subject.otherOncologíaes
dc.subject.otherOncologyes
dc.subject.otherSaludes
dc.subject.otherHealthes
dc.subject.otherMedicinaes
dc.subject.otherMedicinees
dc.titleCharacterisation of the Stromal Microenvironment in Lobular Breast Canceres
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.relation.publisherversionhttps://doi.org/10.3390/cancers14040904es
dc.identifier.doi10.3390/cancers14040904
dc.identifier.essn2072-6694
dc.journal.titleCancerses
dc.volume.number14es
dc.issue.number4es
dc.page.initial904es
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige